# Cormorant Capital's Biotech Investments: 20 Startups in Its Portfolio (2026) > The 20 Biotech startups Cormorant Capital has backed, by stage: $4.6B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/cormorant-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 11 - [Orchard Therapeutics](https://millionrounds.com/company/orchard-therapeutics) - [Solid Biosciences](https://millionrounds.com/company/solid-biosciences) - [*A* Atreca](https://millionrounds.com/company/atreca) - [*ZL* Zai Lab](https://millionrounds.com/company/zai-lab) - [908 Devices](https://millionrounds.com/company/908-devices) - [*TT* TP Therapeutics](https://millionrounds.com/company/tp-therapeutics) - [FORE Biotherapeutics](https://millionrounds.com/company/fore-biotherapeutics) - [*A* Autolous](https://millionrounds.com/company/autolous) - [Cibus](https://millionrounds.com/company/cibus) - [Harpoon](https://millionrounds.com/company/harpoon) - [*A* Axonics](https://millionrounds.com/company/axonics) ## Series B 6 - [Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics) - [Stoke Therapeutics](https://millionrounds.com/company/stoke-therapeutics) - [*R* Replimune](https://millionrounds.com/company/replimune) - [*E* Edios](https://millionrounds.com/company/edios) - [*C* Corvidia](https://millionrounds.com/company/corvidia) - [*C* CMAB](https://millionrounds.com/company/cmab) ## Stage not reported 3 - [BridgeBio](https://millionrounds.com/company/bridgebio) - [*P* Precision](https://millionrounds.com/company/precision) - [*SP* Sasuma Pharmaceuticals](https://millionrounds.com/company/sasuma-pharmaceuticals) ## Segment by segment ### Series C and later 11 startups · $2.0B raised - [**Orchard Therapeutics**](https://millionrounds.com/company/orchard-therapeutics) Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies. United Kingdom $377M - [**Solid Biosciences**](https://millionrounds.com/company/solid-biosciences) Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy. United States $333M - [*A* **Atreca**](https://millionrounds.com/company/atreca) Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. United States $313M - [*ZL* **Zai Lab**](https://millionrounds.com/company/zai-lab) China $310M - [**908 Devices**](https://millionrounds.com/company/908-devices) 908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry. United States $168M - [*TT* **TP Therapeutics**](https://millionrounds.com/company/tp-therapeutics) United States $126M - [**FORE Biotherapeutics**](https://millionrounds.com/company/fore-biotherapeutics) Fore Biotherapeutics is a clinical-stage precision oncology company based in Philadelphia, PA. United States $108M - [*A* **Autolous**](https://millionrounds.com/company/autolous) United Kingdom $80M ### Series B 6 startups · $1.0B raised - [**Akero Therapeutics**](https://millionrounds.com/company/akero-therapeutics) Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state. United States $502M - [**Stoke Therapeutics**](https://millionrounds.com/company/stoke-therapeutics) Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment. United States $255M - [*R* **Replimune**](https://millionrounds.com/company/replimune) United Kingdom $85M - [*E* **Edios**](https://millionrounds.com/company/edios) United States $64M - [*C* **Corvidia**](https://millionrounds.com/company/corvidia) Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases. United States $61M - [*C* **CMAB**](https://millionrounds.com/company/cmab) China $34M ### Stage not reported 3 startups · $1.6B raised - [**BridgeBio**](https://millionrounds.com/company/bridgebio) BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers. United States $1.4B - [*P* **Precision**](https://millionrounds.com/company/precision) United States $111M - [*SP* **Sasuma Pharmaceuticals**](https://millionrounds.com/company/sasuma-pharmaceuticals) United States $62M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Cormorant Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Cormorant Capital** 33 co-investors](https://millionrounds.com/portfolio-maps/cormorant-capital-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **Sequoia Capital's AI portfolio** 209 startups · $543B](https://millionrounds.com/portfolio-maps/sequoia-capital-ai-portfolio) ## Raising from investors like Cormorant Capital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)